United States Biotechnology & Medical Research

Rockwell Medical Inc (RMTI)

Track

Rockwell Medical Inc. has seen no insider trading activity in the last three months. The most recent transactions occurred on January 2, 2026, involving planned and proposed sales by executives, including the COO and CFO. Prior activity throughout 2025 consisted exclusively of various planned and proposed sales by company officers and directors.
Ticker: RMTI Exchange: NMS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Rockwell Medical Inc. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Proposed sale 2 Jan 2026
Value US$3,255,531.77 | Price 49.66 | Shares 85,906
Planned sale 2 Jan 2026
Value US$2,945,862.53 | Price 320.27 | Shares 96,193 (-42.6%)
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-01-05 2026-01-02 PrS Proposed sale
Neri Jesse

Officer

Officer
85,906
49.66
US$3,255,532 		85,906 49.66 US$3,255,532
2026-01-05 2026-01-02 PlS Planned sale
Neri Jesse

SVP and CFO

Officer
96,193 -42.6%
320.27
US$2,945,863 		96,193 -42.6% 320.27 US$2,945,863
2026-01-05 2026-01-02 PlS Planned sale
Hunter Heather

Chief Operating Officer

Officer
53,606 -41.0%
470.79
US$1,262,502 		53,606 -41.0% 470.79 US$1,262,502
2026-01-02 2026-01-02 PrS Proposed sale
Hunter Heather

Officer

Officer
2,868
0.81
US$2,318 		2,868 0.81 US$2,318
2025-11-18 2025-11-18 PrS Proposed sale
1.7
COOPER JOHN G

Director

Non-Executive Director
5,079
0.90
US$4,572 		5,079 0.90 US$4,572
2025-11-18 2025-11-18 S Sale
1.7
COOPER JOHN G
Non-Executive Director
5,079 -3.5%
0.87
US$4,419 		5,079 -3.5% 0.87 US$4,419
2025-10-08 2025-10-01 PlS Planned sale
Hunter Heather

SVP, Chief Operating Officer

Officer
2,868 -2.1%
1.19
US$3,413 		2,868 -2.1% 1.19 US$3,413
2025-10-01 2025-10-01 PrS Proposed sale
Neri Jesse

Officer

Officer
886
1.15
US$1,017 		886 1.15 US$1,017
2025-10-01 2025-10-01 PrS Proposed sale
Strobeck Mark

Officer

Officer
6,926
1.16
US$8,028 		6,926 1.16 US$8,028
2025-10-01 2025-10-01 PrS Proposed sale
Chole Timothy

Officer

Officer
2,868
1.16
US$3,321 		2,868 1.16 US$3,321
2025-10-01 2025-10-01 PlS Planned sale
Strobeck Mark

President and CEO

Executive Director
6,926 -2.1%
1.19
US$8,242 		6,926 -2.1% 1.19 US$8,242
2025-10-01 2025-10-01 PlS Planned sale
Chole Timothy

SVP and CCO

Officer
2,868 -2.2%
1.19
US$3,413 		2,868 -2.2% 1.19 US$3,413
2025-10-01 2025-10-01 PlS Planned sale
Neri Jesse

SVP and CFO

Officer
886 -0.7%
1.19
US$1,054 		886 -0.7% 1.19 US$1,054
2025-07-02 2025-07-01 PlS Planned sale
Neri Jesse

SVP and CFO

Officer
886 -0.7%
0.82
US$727 		886 -0.7% 0.82 US$727
2025-07-02 2025-07-01 PlS Planned sale
Chole Timothy

SVP and CCO

Officer
2,868 -2.2%
0.82
US$2,352 		2,868 -2.2% 0.82 US$2,352
2025-07-02 2025-07-01 PlS Planned sale
Strobeck Mark

President and CEO

Executive Director
6,926 -2.0%
0.82
US$5,679 		6,926 -2.0% 0.82 US$5,679
2025-07-01 2025-07-01 PrS Proposed sale
Strobeck Mark

Officer; Director

Executive Director
6,926
0.80
US$5,536 		6,926 0.80 US$5,536
2025-07-01 2025-07-01 PrS Proposed sale
Chole Timothy

Officer

Officer
2,868
0.79
US$2,271 		2,868 0.79 US$2,271
2025-07-01 2025-07-01 PrS Proposed sale
Neri Jesse

Officer

Officer
886
0.79
US$697 		886 0.79 US$697
2025-04-15 2025-04-11 B Purchase
2.0
Irrevocable Larson Family Investment Trust
Large shareholder
2,000 +0.1%
1.09
US$2,171 		2,000 +0.1% 1.09 US$2,171
2025-04-15 2025-04-11 B Purchase
2.0
Irrevocable Larson Family Investment Trust
Large shareholder
6,000 +0.2%
1.08
US$6,480 		6,000 +0.2% 1.08 US$6,480
2025-04-15 2025-04-11 B Purchase
2.0
Irrevocable Larson Family Investment Trust
Large shareholder
2,000 +0.1%
1.06
US$2,120 		2,000 +0.1% 1.06 US$2,120
2025-04-15 2025-04-11 B Purchase
2.0
Irrevocable Larson Family Investment Trust
Large shareholder
2,000 +0.1%
1.10
US$2,199 		2,000 +0.1% 1.10 US$2,199
2025-04-15 2025-04-11 B Purchase
2.0
Irrevocable Larson Family Investment Trust
Large shareholder
1,500 +0.0%
1.09
US$1,635 		1,500 +0.0% 1.09 US$1,635
2025-04-15 2025-04-11 B Purchase
2.0
Irrevocable Larson Family Investment Trust
Large shareholder
4,000 +0.1%
1.09
US$4,360 		4,000 +0.1% 1.09 US$4,360
2025-04-15 2025-04-11 B Purchase
2.0
Irrevocable Larson Family Investment Trust
Large shareholder
2,000 +0.1%
1.08
US$2,160 		2,000 +0.1% 1.08 US$2,160
2025-04-15 2025-04-11 B Purchase
2.0
Irrevocable Larson Family Investment Trust
Large shareholder
2,000 +0.1%
1.08
US$2,160 		2,000 +0.1% 1.08 US$2,160
2025-04-15 2025-04-11 B Purchase
2.0
Irrevocable Larson Family Investment Trust
Large shareholder
2,000 +0.1%
1.08
US$2,159 		2,000 +0.1% 1.08 US$2,159
2025-04-15 2025-04-11 B Purchase
2.0
Irrevocable Larson Family Investment Trust
Large shareholder
2,000 +0.1%
1.07
US$2,150 		2,000 +0.1% 1.07 US$2,150
2025-04-15 2025-04-11 B Purchase
2.0
Irrevocable Larson Family Investment Trust
Large shareholder
2,000 +0.1%
1.07
US$2,140 		2,000 +0.1% 1.07 US$2,140
2025-04-15 2025-04-11 B Purchase
2.0
Irrevocable Larson Family Investment Trust
Large shareholder
1,000 +0.0%
1.09
US$1,089 		1,000 +0.0% 1.09 US$1,089
2025-04-15 2025-04-11 B Purchase
2.0
Irrevocable Larson Family Investment Trust
Large shareholder
2,000 +0.1%
1.08
US$2,160 		2,000 +0.1% 1.08 US$2,160
2025-04-15 2025-04-10 B Purchase
2.0
Irrevocable Larson Family Investment Trust
Large shareholder
2,000 +0.1%
1.09
US$2,180 		2,000 +0.1% 1.09 US$2,180
2025-04-15 2025-04-10 B Purchase
2.0
Irrevocable Larson Family Investment Trust
Large shareholder
2,000 +0.1%
1.07
US$2,130 		2,000 +0.1% 1.07 US$2,130
2025-04-15 2025-04-10 B Purchase
2.0
Irrevocable Larson Family Investment Trust
Large shareholder
2,000 +0.1%
1.06
US$2,112 		2,000 +0.1% 1.06 US$2,112
2025-04-15 2025-04-10 B Purchase
2.0
Irrevocable Larson Family Investment Trust
Large shareholder
4,000 +0.1%
1.06
US$4,220 		4,000 +0.1% 1.06 US$4,220
2025-04-15 2025-04-10 B Purchase
2.0
Irrevocable Larson Family Investment Trust
Large shareholder
2,000 +0.1%
1.04
US$2,090 		2,000 +0.1% 1.04 US$2,090
2025-04-15 2025-04-10 B Purchase
2.0
Irrevocable Larson Family Investment Trust
Large shareholder
2,000 +0.1%
1.05
US$2,098 		2,000 +0.1% 1.05 US$2,098
2025-04-15 2025-04-10 B Purchase
2.0
Irrevocable Larson Family Investment Trust
Large shareholder
2,000 +0.1%
1.05
US$2,090 		2,000 +0.1% 1.05 US$2,090
2025-04-15 2025-04-10 B Purchase
2.0
Irrevocable Larson Family Investment Trust
Large shareholder
2,000 +0.1%
1.04
US$2,080 		2,000 +0.1% 1.04 US$2,080
2025-04-15 2025-04-10 B Purchase
2.0
Irrevocable Larson Family Investment Trust
Large shareholder
10,000 +0.3%
1.10
US$11,009 		10,000 +0.3% 1.10 US$11,009
2025-04-15 2025-04-10 B Purchase
2.0
Irrevocable Larson Family Investment Trust
Large shareholder
7,000 +0.2%
1.07
US$7,490 		7,000 +0.2% 1.07 US$7,490
2025-04-15 2025-04-10 B Purchase
2.0
Irrevocable Larson Family Investment Trust
Large shareholder
2,000 +0.1%
1.07
US$2,140 		2,000 +0.1% 1.07 US$2,140
2025-04-15 2025-04-10 B Purchase
2.0
Irrevocable Larson Family Investment Trust
Large shareholder
6,000 +0.2%
1.07
US$6,420 		6,000 +0.2% 1.07 US$6,420
2025-04-15 2025-04-10 B Purchase
2.0
Irrevocable Larson Family Investment Trust
Large shareholder
2,000 +0.1%
1.08
US$2,159 		2,000 +0.1% 1.08 US$2,159
2025-04-15 2025-04-10 B Purchase
2.0
Irrevocable Larson Family Investment Trust
Large shareholder
2,000 +0.1%
1.08
US$2,159 		2,000 +0.1% 1.08 US$2,159
2025-04-15 2025-04-10 B Purchase
2.0
Irrevocable Larson Family Investment Trust
Large shareholder
2,000 +0.1%
1.05
US$2,103 		2,000 +0.1% 1.05 US$2,103
2025-04-15 2025-04-10 B Purchase
2.0
Irrevocable Larson Family Investment Trust
Large shareholder
4,000 +0.1%
1.08
US$4,320 		4,000 +0.1% 1.08 US$4,320
2025-04-15 2025-04-10 B Purchase
2.0
Irrevocable Larson Family Investment Trust
Large shareholder
4,000 +0.1%
1.06
US$4,238 		4,000 +0.1% 1.06 US$4,238
2025-04-02 2025-04-01 PlS Planned sale
Chole Timothy

SVP, Chief Commercial Officer

Officer
2,868 -5.9%
1.08
US$3,097 		2,868 -5.9% 1.08 US$3,097
2025-04-02 2025-04-01 PlS Planned sale
Neri Jesse

SVP, FINANCE AND CFO

Officer
886 -2.9%
1.10
US$975 		886 -2.9% 1.10 US$975
2025-04-02 2025-04-01 PlS Planned sale
Strobeck Mark

President and CEO

Executive Director
6,926 -5.3%
1.08
US$7,480 		6,926 -5.3% 1.08 US$7,480
2025-04-01 2025-04-01 PrS Proposed sale
Strobeck Mark

Officer; Director

Executive Director
6,926
1.05
US$7,263 		6,926 1.05 US$7,263
2025-04-01 2025-04-01 PrS Proposed sale
Chole Timothy

Officer

Officer
2,868
1.05
US$3,000 		2,868 1.05 US$3,000
2025-04-01 2025-04-01 PrS Proposed sale
Neri Jesse

Officer

Officer
886
1.06
US$939 		886 1.06 US$939
2025-01-06 2025-01-02 PlS Planned sale
Chole Timothy

SVP, Chief Commercial Officer

Officer
1,001 -1.8%
2.05
US$2,052 		1,001 -1.8% 2.05 US$2,052
2025-01-06 2025-01-02 PlS Planned sale
Strobeck Mark

President and CEO

Executive Director
2,163 -1.5%
2.06
US$4,445 		2,163 -1.5% 2.06 US$4,445
2025-01-02 2025-01-02 PrS Proposed sale
Strobeck Mark

Officer; Director

Executive Director
2,163
2.06
US$4,445 		2,163 2.06 US$4,445
2025-01-02 2025-01-02 PrS Proposed sale
Chole Timothy

Officer

Officer
1,001
2.01
US$2,015 		1,001 2.01 US$2,015
2024-11-19 2024-11-15 S Sale
3.2
RAVICH MARK H
Non-Executive Director
19,991 -100.0%
2.32
US$46,379 		19,991 -100.0% 2.32 US$46,379
2024-11-19 2024-11-15 S Sale
3.2
RAVICH MARK H
Non-Executive Director
10,000 -7.6%
2.40
US$24,000 		10,000 -7.6% 2.40 US$24,000
2024-10-02 2024-10-01 PlS Planned sale
Strobeck Mark

President and CEO

Executive Director
2,163 -1.4%
3.69
US$7,971 		2,163 -1.4% 3.69 US$7,971
2024-10-02 2024-10-01 PlS Planned sale
Chole Timothy

SVP, Chief Commercial Officer

Officer
1,001 -1.8%
3.69
US$3,689 		1,001 -1.8% 3.69 US$3,689
2024-10-01 2024-10-01 PrS Proposed sale
Strobeck Mark

Officer; Director

Executive Director
2,163
3.65
US$7,900 		2,163 3.65 US$7,900
2024-10-01 2024-10-01 PrS Proposed sale
Chole Timothy

Officer

Officer
1,001
3.60
US$3,600 		1,001 3.60 US$3,600
2020-12-23 2020-12-21 S Sale
2.0
Richmond David S.
Large shareholder
42,450 -2.9%
1.03
US$43,724 		42,450 -2.9% 1.03 US$43,724
2020-12-17 2020-12-16 S Sale
2.0
Richmond David S.
Large shareholder
100,000 -62.0%
1.02
US$102,360 		100,000 -62.0% 1.02 US$102,360
2020-12-17 2020-12-16 S Sale
2.0
Richmond David S.
Large shareholder
100,000 -60.7%
1.02
US$102,360 		100,000 -60.7% 1.02 US$102,360
2020-12-17 2020-12-16 S Sale
2.0
Richmond David S.
Large shareholder
136,021 -8.4%
1.01
US$137,123 		136,021 -8.4% 1.01 US$137,123
2020-12-17 2020-12-16 S Sale
2.0
Richmond David S.
Large shareholder
185,855 -5.1%
1.01
US$187,806 		185,855 -5.1% 1.01 US$187,806
2020-12-17 2020-12-15 S Sale
2.0
Richmond David S.
Large shareholder
43,979 -2.7%
1.10
US$48,377 		43,979 -2.7% 1.10 US$48,377
2020-12-17 2020-12-15 S Sale
2.0
Richmond David S.
Large shareholder
234,145 -6.0%
1.11
US$259,128 		234,145 -6.0% 1.11 US$259,128
2020-07-02 2020-06-30 B Purchase
2.0
Richmond David S.
Large shareholder
7,526 +7.8%
1.92
US$14,450 		7,526 +7.8% 1.92 US$14,450
2020-07-02 2020-06-30 B Purchase
2.0
Richmond David S.
Large shareholder
9,946 +11.5%
1.92
US$19,096 		9,946 +11.5% 1.92 US$19,096
2020-07-02 2020-06-30 B Purchase
2.0
Richmond David S.
Large shareholder
650 +442.2%
1.94
US$1,261 		650 +442.2% 1.94 US$1,261
Explore more

More insider trading research around Rockwell Medical Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America